Pruritus, commonly referred to as chronic kidney disease–associated pruritus (CKD-aP), is a distressing and under-recognized symptom among patients with advanced CKD. CKD-aP remains a significant healthcare concern due to its negative impact on patient-reported outcomes, including reduced quality of life, impaired sleep, depression, and anxiety. However, most studies to date have focused on patients receiving haemodialysis. The primary aim of this study was to determine the prevalence of CKD-aP in patients undergoing peritoneal dialysis (PD) and to examine its association with patient-reported outcomes.
Van et al. (2026) studied this question.